Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Capio rejects US$771 mil bid from hospital group Ramsay

2018-07-13 theedgemarkets
STOCKHOLM (July 13): Swedish healthcare company Capio on Friday rejected a bid worth 661 million euros (US$771 million) from the French subsidiary of Australian hospital group Ramsay Health Care, saying it undervalued its business.
RMYHY RHC RMSYF

0
Deals of the day-Mergers and acquisitions

2018-07-13 reuters
July 13 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Friday:
LNGLF RMYHY ANTO ANFGY 532843 5225 ANFGF FORTIS LNGLY RHC 70GD Q0F IHHHF RMSYF LNG

9
Dispensing disruption: Are pharmacies ready for digital rivals?

2018-07-06 theage.com.au
When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted doses of prescribed drugs direct to consumers’ homes, major US-based pharmacies from CVS Health to Walgreens saw their share prices fall about 10 per cent.
EBOSF RMYHY API RHC EBOSY CVS EBO RMSYF EBO

9
Dispensing disruption: Are pharmacies ready for digital rivals?

2018-07-06 smh.com.au
When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted doses of prescribed drugs direct to consumers’ homes, major US-based pharmacies from CVS Health to Walgreens saw their share prices fall about 10 per cent.
EBOSF RMYHY API RHC EBOSY CVS EBO RMSYF EBO

17
Big-name companies leave investors nursing financial bruises in 2018

2018-07-01 theage.com.au
This past weekend should have been party time for Australia’s sharemarket investors. In the 2018 financial year, the S&P/ASX 200 index rewarded investors with a booming total return of around 16 per cent. But you had to invest smart.
PLS MQBKY PILBF RIO RMYHY RIO LYSCF WTCHF MCQEF MAYNF BCHEY BEPTF BPT RTPPF RIO RHC LYSDY RTNTF MQG RMSYF

17
Big-name companies leave investors nursing financial bruises in 2018

2018-07-01 smh.com.au
This weekend should be party time for Australia’s sharemarket investors. In the 2018 financial year, the S&P/ASX 200 index rewarded investors with a booming total return of around 16 per cent. But you had to invest smart.
PLS MQBKY PILBF RIO RMYHY RIO LYSCF WTCHF MCQEF MAYNF BCHEY BEPTF BPT RTPPF RIO RHC LYSDY RTNTF MQG RMSYF

0
'Not at a crisis point yet': Doctors defend going private to give birth

2018-06-28 theage.com.au
A decline in the numbers of women giving birth through the private health system, and associated closures of maternity services at private hospitals, has caused obstetricians to call for government intervention.
RMYHY RHC RMSYF

0
'Not at a crisis point yet': Doctors defend going private to give birth

2018-06-28 smh.com.au
A decline in the numbers of women giving birth through the private health system, and associated closures of maternity services at private hospitals, has caused obstetricians to call for government intervention.
RMYHY RHC RMSYF

0
'Waste of money': women ditch private hospitals, go public to give birth

2018-06-27 theage.com.au
For 32-year-old mother of three Libby Nuttall, giving birth through the private hospital system would have been a “waste of money” .
RMYHY RHC RMSYF

0
'Waste of money': women ditch private hospitals, go public to give birth

2018-06-27 smh.com.au
For 32-year-old mother of three Libby Nuttall, giving birth through the private hospital system would have been a “waste of money” .
RMYHY RHC RMSYF

0
Share market secret could make you a fortune

2018-06-22 ntnews.com.au
A little girl’s reaction to hearing sound for the first time brought tears of joy to her mother, as seen in a sweet video shared on June 19. Cook Children’s, a nonprofit pediatric healthcare organization based in Fort Worth, Texas, shared the video of one-year-old Ayla as her new cochlear implants helped her hear for the first time. In the video, Ayla puts her hand up to her ear with a delighted look on her face, and wiggles on her mom’s lap.
RMYHY RHC RMSYF

0
Just what the doctor ordered: Huge gains for share investors

2018-06-22 perthnow.com.au
IF you’re hoping for healthy gains on the stock market, here’s an investment that’s almost guaranteed to grow.
RMYHY RHC RMSYF

4
ASX advances on investor confidence following tax cuts

2018-06-21 theage.com.au
The Australian sharemarket advanced further on Thursday as index heavyweights across the sectors made strong gains.
AGO RMYHY FSUMF RHC ATLGF AGODY FMG RMSYF FSUGY

4
ASX advances on investor confidence following tax cuts

2018-06-21 smh.com.au
The Australian sharemarket advanced further on Thursday as index heavyweights across the sectors made strong gains.
AGO RMYHY FSUMF RHC ATLGF AGODY FMG RMSYF FSUGY

0
Australian hospital giant Ramsay blames NHS strain for profit warning

2018-06-21 thestar.com.my
Ramsay Health Care Ltd took a charge and cut its outlook for profit growth. - Bloomberg
RMYHY RHC RMSYF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:RHC / RAMSAY HEALTH CARE LIMITED on message board site Silicon Investor.

ERHE - Erhc Energy, Inc. Environmental Remediation (ERHC)
Environmental Remediation Hldg Corp. (ERHC) PRHC: Province Healthcare
KRHC- Rich Coast Resourse RIO HOTEL u0026 CASINO (RHC:NYSE)